HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Packard, C. J. Articles by Shepherd, J. Search for Related Content PubMed PubMed Citation Articles by Packard, C. J. Articles by Shepherd, J. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 23, 1081-1098, Copyright © 1982 by Lipid Research, Inc.

REVIEWS

The hepatobiliary axis and lipoprotein metabolism: effects of bile acid sequestrants and ileal bypass surgery

CJ Packard and J Shepherd

Cholesterol excretion from the body is achieved almost exclusively via the hepatobiliary axis. Disruption of the integrity of this pathway by interruption of the enterohepatic circulation produces profound changes in cholesterol metabolism that affect every body tissue. This is particularly evident in the liver and gut which are the major sources of this sterol in the plasma. Elevated plasma cholesterol levels have been implicated in the pathogenesis of atherosclerosis and, in consequence, strenuous efforts have been made to find appropriate hypocholesterolemic therapy to reduce this risk. Medical or surgical interruption of the enterohepatic circulation is, to date, the most successful means of lowering plasma cholesterol, and in this review we examine the ramifications of such therapy on lipid and lipoprotein metabolism in the liver, gut, and plasma.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Sakamoto, H. Kusuhara, K. Horie, K. Takahashi, T. Baba, J. Ishizaki, and Y. Sugiyama Identification of the Transporters Involved in the Hepatobiliary Transport and Intestinal Efflux of Methyl 1-(3,4-Dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) Glucuronide, a Pharmacologically Active Metabolite of S-8921 Drug Metab. Dispos., August 1, 2008; 36(8): 1553 - 1561. [Abstract] [Full Text] [PDF]

				D. E. Vance, Z. Li, and R. L. Jacobs Hepatic Phosphatidylethanolamine N-Methyltransferase, Unexpected Roles in Animal Biochemistry and Physiology J. Biol. Chem., November 16, 2007; 282(46): 33237 - 33241. [Full Text] [PDF]

				S. Sakamoto, H. Kusuhara, K. Miyata, H. Shimaoka, T. Kanazu, Y. Matsuo, K. Nomura, N. Okamura, S. Hara, K. Horie, et al. Glucuronidation Converting Methyl 1-(3,4-Dimethoxyphenyl)-3-(3-ethylvaleryl)-4-hydroxy-6,7,8-trimethoxy-2-naphthoate (S-8921) to a Potent Apical Sodium-Dependent Bile Acid Transporter Inhibitor, Resulting in a Hypocholesterolemic Action J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 610 - 618. [Abstract] [Full Text] [PDF]

				L. M Stead, J. T Brosnan, M. E Brosnan, D. E Vance, and R. L Jacobs Is it time to reevaluate methyl balance in humans? Am. J. Clinical Nutrition, January 1, 2006; 83(1): 5 - 10. [Abstract] [Full Text] [PDF]

				S. Yoshida and Y. Wada Transfer of maternal cholesterol to embryo and fetus in pregnant mice J. Lipid Res., October 1, 2005; 46(10): 2168 - 2174. [Abstract] [Full Text] [PDF]

				R. H. Knopp Drug Treatment of Lipid Disorders N. Engl. J. Med., August 12, 1999; 341(7): 498 - 511. [Full Text] [PDF]

				J M. L de Vree, J. A Romijn, K. S Mok, L. M. Mathus-Vliegen, C. P Stoutenbeek, J D. Ostrow, G. N. Tytgat, H. P Sauerwein, R. P. O. Elferink, and A. K Groen Lack of enteral nutrition during critical illness is associated with profound decrements in biliary lipid concentrations Am. J. Clinical Nutrition, July 1, 1999; 70(1): 70 - 77. [Abstract] [Full Text] [PDF]

				M. Zoltowska, E. E. Delvin, K. Paradis, E. Seidman, and E. Levy Bile duct cells: a novel in vitro model for the study of lipid metabolism and bile acid production Am J Physiol Gastrointest Liver Physiol, February 1, 1999; 276(2): G407 - G414. [Abstract] [Full Text] [PDF]

				T. Ichihashi, M. Izawa, K. Miyata, T. Mizui, K. Hirano, and Y. Takagishi Mechanism of Hypocholesterolemic Action of S-8921 in Rats: S-8921 Inhibits Ileal Bile Acid Absorption J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 43 - 50. [Abstract] [Full Text]